Skip to main content

Biotechnology Startups

Updated October 2026

Companies in the biotechnology sector developing innovative solutions and technologies.

Explore 5,823 recently funded biotechnology companies with verified founder contact information and fundraising data.

Total Companies
5,823
Total Funding
$1.2B
Avg Funding
$47.0M
Global Reach
6
countries

Top Cities for Biotechnology

Seattle
Canton
Woodinville
Trento
London
Austin

Recently Funded Companies

Export
Seattle, United States

Bonum Therapeutics creates a technology platform to treat a wide range of diseases.

$26.9M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Canton, United States

Orthogon Therapeutics is a drug development company developing antiviral drugs for immune-suppressed patients.

$11.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Woodinville, United States

Briotech is a biotechnology company that supplies pure Hypochlorous Acid formulations for skin care, disinfection, oral care, and more

$6.0M raised
Apr 2025

Founder Contacts

41,000+ verified contacts

Trento, Italy

Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.

$4.8M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Complement Therapeutics operates as a preclinical stage company.

$78.7M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

London, United Kingdom

twig bio operates as a bioengineering startup.

Apr 2026

Founder Contacts

41,000+ verified contacts

Austin, United States

Parachute is a new kind of plasma donation company that allows individuals to earn money while creating life-saving medicine.

$38.1M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.

$56.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Sandy Hook, United States

Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.

$173.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

New York, United States

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

$100.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Eindhoven, The Netherlands

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

$47.8M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

San Carlos, United States

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

$115.0M raised
Apr 2025

Founder Contacts

41,000+ verified contacts

Genoa, Italy

IAMA Therapeutics is a pharmaceutical business that develops novel therapeutics for unmet medical needs in the brain.

$17.1M raised
Apr 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Apr 2025

Founder Contacts

41,000+ verified contacts

Paris, France

Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.

$4.0M raised
Apr 2025

Founder Contacts

41,000+ verified contacts

Dublin, Ireland

Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.

$76.0M raised
Apr 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

$280.0M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Raleigh, United States

Selsym Biotech is a biotechnology developer whose goal is to provide innovative platelet-mimetic therapies for the treatment.

$3.0M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Raleigh, United States

GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders.

$2.5M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Intellistem develops innovative cellular immune cancer treatments.

$1.2M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Paris, France

Smart Immune is a biotech company that helps fight against cancer and infection by providing a thymus-empowered T-cell therapy platform.

$5.0M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

New York, United States

Lunai Bioworks is a biotechnology business committed to developing enhanced allogenic cell and gene therapies.

$20.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Baltimore, United States

Aletira is an emerging biotechnology company based on technologies created at Johns Hopkins University.

$300K raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Pleasanton, United States

AmplifiDx provides a molecular point of care device combining visual appeal with ease of use, low cost and, high performance.

$100K raised
Apr 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.

$108.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Showing 2326 to 2350 of 5,823 companies

About the Biotechnology Startup Ecosystem

The biotechnology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biotechnology

Biotechnology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biotechnology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biotechnology Funding Breakdown

Here is how funding is distributed among the 5,823 biotechnology companies tracked in the VCBacked database.

Average Funding
$47.0M
Total Funding Tracked
$1.2B
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biotechnology

1.Cambridge
3 companies$336.0M
2.London
2 companies$78.7M
3.New York
2 companies$120.0M
4.Paris
2 companies$9.0M
5.Raleigh
2 companies$5.5M

Related Industries

Companies in the biotechnology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biotechnology Startups?

Perfect for: B2B sales teams targeting biotechnology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

5,823 Biotechnology Startups (2026) — Recently Funded — Page 94 | VCBacked